Peijia Medical Limited (HKG:9996)
Hong Kong
· Delayed Price · Currency is HKD 6.36
-0.02 (-0.31%)
Apr 29, 2026, 4:08 PM HKT
Peijia Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 712.87 | 615.48 | 441.13 | 250.83 | 136.53 | Upgrade
|
| Revenue Growth (YoY) | 15.82% | 39.52% | 75.86% | 83.71% | 253.21% | Upgrade
|
| Cost of Revenue | 226.82 | 181.86 | 115.76 | 74.63 | 40.88 | Upgrade
|
| Gross Profit | 486.05 | 433.62 | 325.37 | 176.2 | 95.65 | Upgrade
|
| Selling, General & Admin | 446.83 | 479.44 | 466.62 | 365.06 | 207.68 | Upgrade
|
| Research & Development | 254.36 | 203.42 | 205.5 | 147.02 | 131.3 | Upgrade
|
| Other Operating Expenses | -19 | -19.54 | -18.13 | -12.76 | -7.46 | Upgrade
|
| Operating Expenses | 682.19 | 663.32 | 653.98 | 499.32 | 331.52 | Upgrade
|
| Operating Income | -196.14 | -229.7 | -328.61 | -323.12 | -235.87 | Upgrade
|
| Interest Expense | -11.73 | -4.74 | -0.18 | -2.32 | -0.19 | Upgrade
|
| Interest & Investment Income | 7.81 | 22.48 | 39.44 | 46.63 | 24.77 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.17 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -12.05 | 5.7 | -17.78 | 106.42 | -48.14 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.27 | - | Upgrade
|
| EBT Excluding Unusual Items | -212.11 | -206.25 | -307.13 | -172.28 | -259.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.46 | -14.98 | 3.77 | 0.58 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.05 | -0.37 | -0.22 | -0.03 | -0.22 | Upgrade
|
| Other Unusual Items | - | - | -87.92 | -226.51 | -314.58 | Upgrade
|
| Pretax Income | -202.6 | -221.6 | -391.5 | -398.24 | -574.22 | Upgrade
|
| Income Tax Expense | 5.59 | 6.89 | 1.05 | 9.57 | - | Upgrade
|
| Earnings From Continuing Operations | -208.18 | -228.49 | -392.55 | -407.81 | -574.22 | Upgrade
|
| Minority Interest in Earnings | 4.9 | 1.92 | 0.03 | - | - | Upgrade
|
| Net Income | -203.29 | -226.58 | -392.53 | -407.81 | -574.22 | Upgrade
|
| Net Income to Common | -203.29 | -226.58 | -392.53 | -407.81 | -574.22 | Upgrade
|
| Shares Outstanding (Basic) | 665 | 669 | 679 | 673 | 662 | Upgrade
|
| Shares Outstanding (Diluted) | 665 | 669 | 679 | 673 | 662 | Upgrade
|
| Shares Change (YoY) | -0.64% | -1.44% | 0.91% | 1.74% | 41.68% | Upgrade
|
| EPS (Basic) | -0.31 | -0.34 | -0.58 | -0.61 | -0.87 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.34 | -0.58 | -0.61 | -0.87 | Upgrade
|
| Free Cash Flow | - | -254.32 | -806.54 | -506.61 | -506.11 | Upgrade
|
| Free Cash Flow Per Share | - | -0.38 | -1.19 | -0.75 | -0.77 | Upgrade
|
| Gross Margin | 68.18% | 70.45% | 73.76% | 70.25% | 70.06% | Upgrade
|
| Operating Margin | -27.51% | -37.32% | -74.49% | -128.82% | -172.75% | Upgrade
|
| Profit Margin | -28.52% | -36.81% | -88.98% | -162.58% | -420.57% | Upgrade
|
| Free Cash Flow Margin | - | -41.32% | -182.84% | -201.97% | -370.68% | Upgrade
|
| EBITDA | -142.73 | -176.29 | -291.65 | -292.57 | -212.61 | Upgrade
|
| EBITDA Margin | -20.02% | -28.64% | -66.11% | -116.64% | -155.72% | Upgrade
|
| D&A For EBITDA | 53.41 | 53.41 | 36.96 | 30.54 | 23.26 | Upgrade
|
| EBIT | -196.14 | -229.7 | -328.61 | -323.12 | -235.87 | Upgrade
|
| EBIT Margin | -27.51% | -37.32% | -74.49% | -128.82% | -172.75% | Upgrade
|
| Advertising Expenses | 83.88 | 77.41 | 67.53 | 48.12 | 14.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.